Google
×
3 days ago · Investors Relations. IR Home · Why Invest ... Ironwood Pharmaceuticals (Nasdaq: IRWD), an ... Ironwood Pharmaceuticals Q4 and Full Year 2023 ...
Investors Relations. IR Home · Why Invest · Events ... Events & Presentations. NASDAQ: IRWD8.96+0.34 (3.94%) ... Q4 and FY 2023 Investor Update. More Information
NASDAQ: IRWD8.71+0.091.04%Volume: 2,699,381March ... Q3 Financial Performance and 2022 Financial Guidance ... Director, Investor Relations 617.621.8395 MRoache ...
State law regulates IRWD as to the types of fixed-income securities in which it can invest cash assets. In addition, the Board of Directors annually adopts an ...
Class A Common Stock (IRWD) including earnings per share, earnings forecasts at Nasdaq ... Investor Relations Intelligence. Featured ... IRWD IRWD EARNINGS DATE ...
Our website is dedicated to our customers' right to expect transparent government and easy to access information. We want to ensure that our compensation ...
People also ask
Vice President of Strategic Finance & Investor Relations, N/A, N/A, N/A. Ms. Beth Calitri, Head of Corporate Communications & Media Relations, N/A, N/A, N/A. Mr ...
Access Ironwood Pharmaceuticals Inc (IRWD) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using ...
Feb 15, 2024 · (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript February 15, 2024 8:30 AM ET. Company Participants. Matt Roache - Director of Investor Relations.
(Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2023 investor update conference call and webcast at 8:30 a.m. Eastern Time on ...